A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia.

Lucy E VivashCharles B MalpasLeonid ChurilovMark WalterfangAmy BrodtmannOlivier PiguetRebekah M AhmedAshley I BushChristopher M HovensT KalincikDavid DarbyDennis VelakoulisTerence J O'Brien

Published in: BMJ open (2020)

ACTRN12620000236998 .

Keyphrases

double blind
phase ii
placebo controlled
clinical trial
open label
phase iii
study protocol
randomized controlled trial
replacement therapy
smoking cessation